Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"adherence"

Slides: 1–12 of 49
Add to tray Remove from tray

Rationale for Update

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: systematic review | comparative effectiveness | ACEI | ARB | hypertension | aliskiren | DRI
Add to tray Remove from tray

Patient Cost Information

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: adherence | antihypertensive agents | generic | wholesale | cost
Add to tray Remove from tray

What To Discuss With Your Patients

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: barriers | blood pressure medication | shared decisionmaking | tradeoffs | patients
Effects of Run-in Periods and Prerandomization Exclusion Criteria. Why might trials with run-in periods and high prerandomization exclusion rates negatively affect applicability? A. The adverse events seen in the intervention groups would likely be lower than in the clinical setting. B. The benefits seen in the intervention groups would likely be lower than in the clinical setting. C. Run-in periods should not negatively affect applicability.
Add to tray Remove from tray

Effects of Run-in Periods and Prerandomization Exclusion Criteria

Presentation: Assessing Applicability Quiz
Add to tray Remove from tray

Operationalizing the Comparison Group in Comparative Effectiveness Research (2 of 2)

Presentation: Comparator Selection in Observational Comparative Effectiveness Research
Keywords: exposure time window | nonadherence | dose | comparators
Add to tray Remove from tray

Considerations for Comparisons Across Different Treatment Modalities (3 of 3)

Presentation: Comparator Selection in Observational Comparative Effectiveness Research
Keywords: adherence | provider effects | treatment modalities
Add to tray Remove from tray

What to Discuss With Your Patients

Presentation: Comparing Medications for Adults With Type 2 Diabetes
Keywords: patients | shared decisionmaking | goals | adherence | reporting adverse events
Add to tray Remove from tray

Shared Decisionmaking: What To Discuss With Your Patients

Presentation: Comparisons of Medical, Laser, and Incisional Surgical Treatments for Open-Angle Glaucoma in Adults
Keywords: adherence | benefits | patients | side effects | treatment | shared decisionmaking
Add to tray Remove from tray

Sources of Confounding

Presentation: Covariate Selection for Observational Comparative Effectiveness Research
Keywords: confounding | provider actions | patient actions | environmental factors | social factors
Add to tray Remove from tray

Causal Models and the Structural Relationship of Variables (5 of 7) Time-varying confounding Causal Models and the Structural Relationship of Variables (5 of 7)

Presentation: Covariate Selection for Observational Comparative Effectiveness Research
Keywords: causal models | time-varying confounding
Add to tray Remove from tray

Proxy Confounders and Mismeasured and Unmeasured Confounders

Presentation: Covariate Selection for Observational Comparative Effectiveness Research
Keywords: proxy confounders | mismeasured and unmeasured confounders | sensitivity analysis
Add to tray Remove from tray

Knowledge Gaps and Future Research Needs

Presentation: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Keywords: knowledge gaps | future research needs | insufficient evidence | apnea-hypopnea index | AHI | mandibular advancement device | MAD | continuous positive airway pressure | CPAP | treatment | surgery
Pages: [1] 2 3 4 5 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364